Skip to main content

Table 2 Baseline characteristics

From: In-hospital cardiac arrest incidence and outcomes in the era of COVID-19: an observational study in a Singapore hospital

  Pre-COVID-19 period (n = 34) COVID-19 period (n = 46) P value
Age (year) 70.8 ± 12.7 65.0 ± 12.8 0.04
Male gender (%) 23 (64.8) 28 (66.4) 0.42
DM (%) 24 (68.9) 28 (65.5) 0.74
Hypertension (%) 17 (54.4) 22 (48.7) 0.27
IHD (%) 10 (24.8) 10 (28.6) 0.39
CVA (%) 8 (18.1) 12 (16.8) 0.85
Chronic kidney disease (%) 9 (23.2) 13 (31.1) 0.93
Chronic lung disease (%) 5 (12.0) 7 (14.3) 0.99
Chronic liver disease (%) 1 (8.0) 1 (5.8) 0.81
Malignancy (%) 6 (14.4) 1 (8.4) 0.01
APACHE II Score 29.1 ± 10.1 29.3 ± 9.2 0.93
HCBT response time (min) 2.45 ± 1.25 3.50 ± 2.12 0.01
  1. DM diabetes mellitus, IHD ischaemic heart disease, CVA cerebrovascular accident, APACHE II Acute Physiology And Chronic Health Evaluation II, HCBT hospital code blue team